SCHEMBL18697135

SCHEMBL18697135

Cc1cc(F)c(N)nc1C

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.39
NOS1 P29475 2/20 0.39
NOS2 P35228 2/20 0.39
KHK P50053 1/20 0.38
CYP1A2 P05177 1/20 0.35
LMNA P02545 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
RAD52 P43351 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
DHFR P00374 3/20 0.33
TERT O14746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15979054 0.83 KHK (0.39) NOS3NOS1NOS2KHKLMNA
SCHEMBL7169609 0.83 KHK (0.39) NOS3NOS1NOS2KHKLMNA
SCHEMBL20355266 0.81 KHK (0.38) NOS3NOS1NOS2KHKKDM4E
SCHEMBL10144932 0.81 NOS3 (0.38) NOS3NOS1NOS2KHKLMNA
SCHEMBL21047969 0.77 LMNA (0.41) KHKLMNAALDH1A1KMT2ATERT
SCHEMBL16501095 0.77 KHK (0.44) KHKLMNAKDM4EALDH1A1SMN1; SMN2
SCHEMBL26688044 0.77 KHK (0.36) KHKLMNA
SCHEMBL4331730 0.77 NOS3 (0.33) NOS3NOS1NOS2CYP1A2SMN1; SMN2
SCHEMBL9753602 0.77 NOS3 (0.44) NOS3NOS1NOS2CYP1A2LMNA
SCHEMBL28292898 0.77 NOS3 (0.44) NOS3NOS1NOS2CYP1A2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4389751-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF Kumquat Biosciences Inc. (US) 2024-06-26 EP disclosed
EP-4265607-A1 AMINOPYRIDINE COMPOUND AND APPLICATION THEREOF Medshine Discovery Inc. (CN) 2023-10-25 EP disclosed
EP-3766876-B1 PHARMACEUTICAL FORMULATION CONTAINING A QUINOLONE DERIVATIVE MELINTA SUBSIDIARY CORP (US) 2023-09-13 EP disclosed
EP-2346855-B1 PROCESS FOR MAKING QUINOLONE COMPOUNDS MELINTA THERAPEUTICS INC (US) 2017-04-05 EP disclosed